Lau Joanne, Syed Huzaefah J, Ellenbogen Kenneth A, Kron Jordana
Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
Division of Rheumatology, Allergy and Immunology, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
J Innov Card Rhythm Manag. 2018 Feb 15;9(2):3016-3021. doi: 10.19102/icrm.2018.090203. eCollection 2018 Feb.
Cardiac sarcoidosis (CS) can cause atrial and ventricular arrhythmias, conduction system disease, and congestive heart failure. The use of advanced imaging modalities including cardiac magnetic resonance and positron emission tomography with 2-deoxy-2-[fluorine-18]fluoro-D-glucose can be helpful in evaluating the extent of disease and response to treatment. The management of CS patients can be challenging, requiring immunosuppression medications, antiarrhythmic drugs, implantable cardiac devices, and cardiac ablation procedures. We report a patient with CS initially presenting with paroxysmal atrial fibrillation who later developed polymorphic ventricular tachycardia, highlighting the complexity of diagnosis and management in patients with multisystem sarcoidosis.
心脏结节病（CS）可导致房性和室性心律失常、传导系统疾病以及充血性心力衰竭。使用包括心脏磁共振成像和2-脱氧-2-[氟-18]氟-D-葡萄糖正电子发射断层扫描在内的先进成像方式，有助于评估疾病的范围以及对治疗的反应。CS患者的管理具有挑战性，需要使用免疫抑制药物、抗心律失常药物、植入式心脏装置以及心脏消融手术。我们报告了一名最初表现为阵发性心房颤动，后来发展为多形性室性心动过速的CS患者，突出了多系统结节病患者诊断和管理的复杂性。
